Overview
DXCM market data
Price History
DXCM price chart
Valuation & Profitability
- P/E (TTM)
- 32.48 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $2.06 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.48 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 20.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $54.11 – $91.04 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $32.5B · P/B 9.43 · P/S 6.53.
Company News
Argus Research Maintains Buy on DexCom, Raises Price Target to $96Benzinga · Aug 4, 2026, 2:17 PM
Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $90Benzinga · Aug 3, 2026, 9:19 PM
Citigroup Maintains Buy on DexCom, Raises Price Target to $88Benzinga · Jul 31, 2026, 8:21 PM
RBC Capital Maintains Outperform on DexCom, Raises Price Target to $90Benzinga · Jul 31, 2026, 6:49 PM
Mizuho Maintains Outperform on DexCom, Raises Price Target to $95Benzinga · Jul 31, 2026, 5:49 PM
Stock Market Today: Amazon Jumps 15%, Apple Wipes Out $475 BillionBenzinga · Jul 31, 2026, 5:42 PM
JP Morgan Maintains Neutral on DexCom, Raises Price Target to $82Benzinga · Jul 31, 2026, 5:25 PM
DexCom shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance. Also, multiple analysts raised their respective price targets on the stock.Benzinga · Jul 31, 2026, 2:59 PM
Piper Sandler Reiterates Overweight on DexCom, Raises Price Target to $95Benzinga · Jul 31, 2026, 2:47 PM
Wells Fargo Maintains Overweight on DexCom, Raises Price Target to $90Benzinga · Jul 31, 2026, 2:31 PM